News
The blood cancer market is experiencing robust growth, driven by rising incidence rates and advancements in targeted therapies and immuno-oncology. I ...
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) has announced the appointment of Dr. Karen Smith, MD, PhD, MBA, ...
The U.S. Food and Drug Administration has announced a major warning about a popular baked beans brand. Vietti Food Group of ...
During a live event, Daniel M. Geynisman, MD, and participants discussed which efficacy end points they value and how they ...
COPD cases are rising in women. Uncover the latest insights to enhance diagnosis and treatment in your women patients.
PHILADELPHIA, May 05, 2025 (GLOBE NEWSWIRE ... Medical Officer of Jazz Pharmaceuticals and has also held senior leadership roles at Allergan, AstraZeneca, and Bristol Myers Squibb. "As we take the ...
Board Member Dr. Karen Smith to serve as Interim Chief Medical OfficerPHILADELPHIA, May 05, 2025 (GLOBE NEWSWIRE) -- Context ...
The Super Bowl champion Philadelphia Eagles can improve on the league's best roster in the 2025 NFL draft. With Brandon Graham's retirement and Milton Williams leaving via free agency, the Eagles ...
10d
Audacy on MSNMerck invests $1B in Wilmington facility to boost U.S. drug production amid tariff concernsU.S. drug maker Merck is building a $1 billion facility in Wilmington, Delaware, aimed at increasing domestic production of ...
Washington (DC News Now) — t’s a homecoming for DC’s football team. DC Mayor Muriel Bowser (D) announcing a deal this week with the Washington Commanders to build a new stadium ...
The firm is expecting Phase III readouts this year for its FGFR2b drug bemarituzumab and is advancing a second KRAS inhibitor to the clinic.
London's FTSE 100 index, which has gained 4.8% since the beginning of the year, was 0.8% higher at 1:00 p.m. in the U.K. on Friday — putting it on track for its longest ever run of daily gains.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results